Combined common femoral artery endarterectomy with superficial femoral artery stenting plus Shuxuening Injection (舒血宁注射液) infusion for chronic lower extremity ischemia: 3-year results

Hai Feng; Xue-ming Chen; Chen-yu Li; Ren-ming Zhu; Jie Fang; Tian-you Wang

doi:10.1007/s11655-012-1113-z

Your Location：

Home >

Browse articles >

Combined common femoral artery endarterectomy with superficial femoral artery stenting plus Shuxuening Injection (舒血宁注射液) infusion for chronic lower extremity ischemia: 3-year results

OriginalPaper | Updated：2021-08-27

- Combined common femoral artery endarterectomy with superficial femoral artery stenting plus Shuxuening Injection (舒血宁注射液) infusion for chronic lower extremity ischemia: 3-year results
- Combined common femoral artery endarterectomy with superficial femoral artery stenting plus Shuxuening Injection (舒血宁注射液) infusion for chronic lower extremity ischemia: 3-year results
- 中国结合医学杂志（英文版） 2012年18卷第6期页码：417-422
- Affiliations：
  
  Department of Vascular Surgery, Beijing Friendship Hospital, Capital Medical University,Beijing,China
- Author bio：
- Funds：
- DOI：10.1007/s11655-012-1113-z
  中图分类号：
- 纸质出版日期：2012，
  
  网络出版日期：2012-4-11，
Scan for full text
Feng, H., Chen, Xm., Li, Cy. et al. Combined common femoral artery endarterectomy with superficial femoral artery stenting plus Shuxuening Injection (舒血宁注射液) infusion for chronic lower extremity ischemia: 3-year results., Chin. J. Integr. Med. 18, 417–422 (2012). https://doi.org/10.1007/s11655-012-1113-z

Hai Feng, Xue-ming Chen, Chen-yu Li, et al. Combined common femoral artery endarterectomy with superficial femoral artery stenting plus Shuxuening Injection (舒血宁注射液) infusion for chronic lower extremity ischemia: 3-year results[J]. Chinese Journal of Integrative Medicine, 2012,18(6):417-422.
Feng, H., Chen, Xm., Li, Cy. et al. Combined common femoral artery endarterectomy with superficial femoral artery stenting plus Shuxuening Injection (舒血宁注射液) infusion for chronic lower extremity ischemia: 3-year results., Chin. J. Integr. Med. 18, 417–422 (2012). https://doi.org/10.1007/s11655-012-1113-z DOI：

Hai Feng, Xue-ming Chen, Chen-yu Li, et al. Combined common femoral artery endarterectomy with superficial femoral artery stenting plus Shuxuening Injection (舒血宁注射液) infusion for chronic lower extremity ischemia: 3-year results[J]. Chinese Journal of Integrative Medicine, 2012,18(6):417-422. DOI： 10.1007/s11655-012-1113-z.

摘要

To investigate the efficacy and safety of combined common femoral artery (CFA) endarterectomy with superficial femoral artery (SFA) stenting plus Shuxuening Injection (舒血宁注射液) infusion in patients with complex multifocal arterial steno-obstructive lesions of the lower extremities. From March 2006 to March 2011

104 lower limbs in 96 patients with multilevel peripheral arterial steno-occlusive disease

involving SFA as well as CFA and deep femoral artery (DFA) orifice

were treated by combined surgical with endovascular therapy

such as SFA stenting as an adjunct to CFA endarterectomy and patch angioplasty with the great saphenous vein. Before the end of the operation

20 mL of Shuxuening Injection was infused through the catheter located in the treated artery. Technical and hemodynamic success

as well as primary and primary-assisted patency

was determined according to the Society for Vascular Surgery Guidelines. During follow-up

clinical status assessment

ankle-brachial index (ABI) test

and duplex Doppler ultrasound were administered every 6 months

and computed tomography angiography or magnetic resonance angiography was performed at 12

and 36 months after discharge. All patients underwent successful combined CFA endarterectomy with SFA stenting treatment. The average ABI after the combination treatment increased from pretreatment of 0.32±0.21 to 0.82±0.24 (P<0.01). No perioperative death and major limb amputations occurred. The mean duration of follow-up for 104 limbs from 96 patients was 1

180 days (range

196–2

064 days). During follow-up

5 patients died due to myocardial infarction

cerebral infarction

or pneumonia

and 5 patients were lost to follow-up. There were 21 cases (21.4%) of restenosis

with 15 that occurred in-stent and 6 near the distal end of the stent. A total of 18 (18.3%) reinterventions were performed

including 6 balloon angioplasty

8 restenting procedures

2 bypass surgeries

and 2 major limb amputations. The primary patency rates were 92.2%

76.8%

and 61.3% at 12

and 36 months

respectively

while the primary-assisted patency rates were 94.4%

83.2%

and 75.6% at 12

and 36 months

respectively. The combined CFA endarterectomy with SFA stenting plus Shuxuening Injection infusion appears to offer a safe

less invasive

and effective treatment option to patients with chronic lower extremity ischemia due to complex multifocal peripheral artery disease.

Abstract

104 lower limbs in 96 patients with multilevel peripheral arterial steno-occlusive disease

involving SFA as well as CFA and deep femoral artery (DFA) orifice

were treated by combined surgical with endovascular therapy

such as SFA stenting as an adjunct to CFA endarterectomy and patch angioplasty with the great saphenous vein. Before the end of the operation

20 mL of Shuxuening Injection was infused through the catheter located in the treated artery. Technical and hemodynamic success

as well as primary and primary-assisted patency

was determined according to the Society for Vascular Surgery Guidelines. During follow-up

clinical status assessment

ankle-brachial index (ABI) test

and duplex Doppler ultrasound were administered every 6 months

and computed tomography angiography or magnetic resonance angiography was performed at 12

180 days (range

196–2

064 days). During follow-up

5 patients died due to myocardial infarction

cerebral infarction

or pneumonia

and 5 patients were lost to follow-up. There were 21 cases (21.4%) of restenosis

with 15 that occurred in-stent and 6 near the distal end of the stent. A total of 18 (18.3%) reinterventions were performed

including 6 balloon angioplasty

8 restenting procedures

2 bypass surgeries

and 2 major limb amputations. The primary patency rates were 92.2%

76.8%

and 61.3% at 12

and 36 months

respectively

while the primary-assisted patency rates were 94.4%

83.2%

and 75.6% at 12

and 36 months

respectively. The combined CFA endarterectomy with SFA stenting plus Shuxuening Injection infusion appears to offer a safe

less invasive

and effective treatment option to patients with chronic lower extremity ischemia due to complex multifocal peripheral artery disease.

关键词

chronic lower extremity ischemiaendarterectomystentingangioplastyShuxuening Injectionhybrid technique

Keywords

chronic lower extremity ischemiaendarterectomystentingangioplastyShuxuening Injectionhybrid technique

references

Andrews RT, Venbrux AC, Magee CA, Bova DA. Placement of a flexible endovascular stent across the femoral joint: an in vivo study in the swine model. J Vasc Interv Radio 1999;10:1219–1228.

Ballard JL, Sparks SR, Taylor FC, Bergan JJ, Smith DC, Bunt TJ, et al. Complications of iliac artery stent deployment. J Vasc Surg 1996;24:545–555.

Zhou W, Chai H, Lin PH, Lumsden AB, Yao Q, Chen C. Clinical use and molecular mechanisms of action of extract of Ginkgo biloba leaves in cardiovascular disease. Cardiovasc Drug Rev 2004;22:309–319.

Kleijnen J, Knipschild P. Ginkgo biloba for cerebral insufficiency. Br J Clin Pharmacol 1992;34:352–358

Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes. TASC II Working Group. Inter-society consensus for the management of peripheral arterial disease. J Vasc Surg 2007;45(Suppl):S5–67.

Cotroneo AR, Jezzi R, Marano G, Fonio P, Nessi F, Gandini G, et al. Hybrid therapy in patients with complex peripheral multifocal steno-obstructive vascular disease: two-year results. Cardiovasc Interv Radio 2007;30:355–361.

Schillinger M, Sabeti S, Loewe C, Dick P, Amighi J, Mlekusch W. Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery. New Engl J Med 2006;354:1879–1888.

Mewissen MW. Sel f -expanding ni t inol stents in the femoropopliteal segment: technique and mid-term results. Tech Vasc Interv Radio 2004;7:2–5.

Sabeti S, Schillinger M, Amighi J, Sherif C, Mlekusch W, Ahmadi R, et al. Primary patency of femoropopliteal arteries treated with nitinol versus stainless steel self-expanding stents: propensity score-adjusted analysis. Radiology 2004;232:516–521.

Nishibe T, Kondo Y, Nishibe M, Muto A, Dardik A, Nishibe T. Stent placement of femoropopliteal arterial occlusive disease in high-risk patients: preliminary results. Surg Today 2009;39:21–26.

Myers KA. Reporting standards and statistics for evaluating intervention. Cardiovasc Surg 1995;3:455–461.

Ballotta E, Gruppo M, Mazzalai F, Da Giau G. Common femoral artery endarterectomy for occlusive disease: an 8-year single-center prospective study. Surgery 2010;147:268–274.

Nelson PR, Powell RJ, Schermerhorn ML, Fillinger MF, Zwolak RM, Walsh DB, et al. Early results of external iliac artery stenting combined with common femoral artery endarterectomy. J Vasc Surg 2002;35:1107–1113.

Mousa A, Abdel-Hamid M, Ewida A, Saad M, Sahrabi A. Combined percutaneous endovascular iliac angioplasty and infrainguinal surgical revascularization for chronic extremity ischemia: preliminary result. Intern Soc Vasc Surg 2010;18:71–76.

Edwards WH Jr, Martin RS III, Jenkins JM, Edwards WH Sr, Mulherin JL Jr. Primary graft infections. J Vasc Surg 1987;6:235–239.

Pons VG, Wurtz R. Vascular graft infections: a 25-year experience of 170 cases. J Vasc Surg 1991;13:751–753.

Kemmel RM, Murphy RX, Chowdary RP. Optimal management of inguinal vascular graft infections. Ann Plast Surg 1994;32:623–629.

Spence MT, David AW, Eugene ML, Jonathan SL. Outcomes in the management of vascular prosthetic graft infections confined to groin: a reappraisal. Ann Vasc Surg 1996;10:117–122.

Bao YM, Liu AH, Zhang ZX, Li Y, Wang XY. Effects of Ginkgo biloba extract 50 preconditioning on contents of inflammation-related cytokines in myocardium of rats with ischemia-reperfusion injury. J Chin Integr Med (Chin) 2010;8:373–378.

Yuan LP, Chen ZW, Li F, Dong LY, Chen FH. Protective effect of total flavones of rhododendra on ischemic myocardial injury in rabbits. Am J Chin Med 2006;34:483–492.

Saleem S, Zhuang H, Biswal S, Christen Y, Dore S. Ginkgo biloba extract neuroprotective action is dependent on heme oxygenase 1 in ischemic reperfusion brain injury. Stroke 2008;12:3389–3396.

Pittler MH, Ernst E. Ginkgo biloba extract for the treatment of intermittent claudication: a meta-analysis of randomized trials. Am J Med 2000;108:276–281.

Peters H, Kieser M, Holscher U. Demonstration of the efficacy of ginkgo biloba special extract EGb 761 on intermittent claudication-a placebo-controlled, double-blind multicenter trial. Vasa 1998;27:106–110.

Klinkert P, Post PN, Breslau PJ, van Bockel JH. Saphenous vein versus PTFE for above-knee femoropopliteal bypass. A review of the literature. Eur J Vasc Endovasc Surg 2004;27:357–362.

Takagi H, Goto SN, Matsui M, Manabe H, Umemoto T. A contemporary meta-analysis of Dacron versus polytetrafluoroethylene grafts for femoropopliteal bypass grafting. J Vasc Surg 2010;52:232–236.

Reed AB. Endovascular as an open adjunct: use of hybrid endovascular treatment in the SFA. Semin Vasc Surg 2008;21:200–203.

Sikkink CI, Reijnen MM, Zeebregts CI. The creation of the optimal dedicated endovascular suite. Eur J Endovasc Surg 2008;35:198–204.

Ebaugh JL, Gagnon D, Owens CD, Conte MS, Raffeto JD. Comparison of costs of staged versus simultaneous lower extremity arterial hybrid procedures. Am J Surg 2008;196:634–640.

FULL TEXT LINK

More>

浏览量

Downloads

CSCD

文章被引用时，请邮件提醒。

Submit

工具集

关联资源

Effect of shuxinyin on in-stent restenosis after coronary artery stenting

Clinical study of xiongshao capsule in preventing restenosis after coronary interventional treatment

Effect of xiongshao capsule on vascular remodeling in porcine coronary balloon injury model